Unique human immune signature of Ebola virus disease in Guinea

[1]  K. Lokuge,et al.  Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. , 2015, Journal of Clinical Investigation.

[2]  G. Ippolito,et al.  Blood kinetics of Ebola virus in survivors and nonsurvivors. , 2015, The Journal of clinical investigation.

[3]  C. Basler,et al.  Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus , 2015, Nature Reviews Microbiology.

[4]  S. Günther,et al.  Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain , 2015, Emerging infectious diseases.

[5]  T. Vogl,et al.  Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care , 2015, The Lancet.

[6]  Jay B. Varkey,et al.  Human Ebola virus infection results in substantial immune activation , 2015, Proceedings of the National Academy of Sciences.

[7]  T. Renné,et al.  A case of severe Ebola virus infection complicated by gram-negative septicemia. , 2014, The New England journal of medicine.

[8]  Rachel S. G. Sealfon,et al.  Clinical illness and outcomes in patients with Ebola in Sierra Leone. , 2014, The New England journal of medicine.

[9]  S. H. van der Burg,et al.  Anti–CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response , 2014, Science Translational Medicine.

[10]  Timothy D. Flietstra,et al.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome. , 2014, The Journal of infectious diseases.

[11]  T. Okazaki,et al.  A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application , 2013, Nature Immunology.

[12]  E. Yang,et al.  Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation , 2013, Nature Immunology.

[13]  F. Sánchez‐Madrid,et al.  Immunoregulatory molecules are master regulators of inflammation during the immune response , 2012, FEBS letters.

[14]  J. Allison,et al.  Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans , 2012, The Journal of Immunology.

[15]  L. Rénia,et al.  The CTLA-4 and PD-1/PD-L1 Inhibitory Pathways Independently Regulate Host Resistance to Plasmodium-induced Acute Immune Pathology , 2012, PLoS pathogens.

[16]  L. Walker,et al.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses , 2011, Nature Reviews Immunology.

[17]  H. Ljunggren,et al.  Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection , 2011, Journal of Virology.

[18]  E John Wherry,et al.  T cell exhaustion , 2011 .

[19]  P. Bousso,et al.  Faculty Opinions recommendation of Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. , 2011 .

[20]  G. Anderson,et al.  Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 , 2011, Science.

[21]  A. Theofilopoulos,et al.  Impaired negative regulation of homeostatically proliferating T cells. , 2009, Blood.

[22]  J. Altman,et al.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.

[23]  P. Rollin,et al.  Cytokine and chemokine expression in humans infected with Sudan Ebola virus. , 2007, The Journal of infectious diseases.

[24]  E. Rosenberg,et al.  Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction , 2007, Nature Immunology.

[25]  M. Slifka,et al.  Pivotal Advance: CTLA‐4+ T cells exhibit normal antiviral functions during acute viral infection , 2007, Journal of leukocyte biology.

[26]  K. Sundar,et al.  Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes. , 2007, Virology.

[27]  T. Ichiyama,et al.  Expression of CTLA‐4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection , 2004, Clinical and experimental immunology.

[28]  G. Simmons,et al.  Identification of murine T-cell epitopes in Ebola virus nucleoprotein. , 2004, Virology.

[29]  J. Bodmer,et al.  HLA class I in three West African ethnic groups: genetic distances from sub-Saharan and Caucasoid populations. , 2001, Tissue antigens.

[30]  P. Debré,et al.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients , 1999, Nature Medicine.

[31]  P. Linsley,et al.  Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. , 1992, Science.